Propanc Biopharma Shares Advance Following Nasdaq Debut-March 2024-www.financetom.com

Propanc Biopharma Shares Advance Following Nasdaq Debut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Propanc Biopharma Shares Advance Following Nasdaq Debut

Aug 18, 2025 8:09 AM

10:52 AM EDT, 08/18/2025 (MT Newswires) -- Propanc Biopharma ( PPCB ) shares jumped more than 146% in recent Monday trading following their debut on Nasdaq on Friday.

Intraday trading volume was more than 48 million shares.

The company said last week it expects to close on Monday its initial public offering of 1 million shares.

Price: 7.08, Change: +4.21, Percent Change: +146.52

Previous page： Market Chatter: Documents Reveal Canada Federal Govt's Efforts to Get Loblaw, Walmart On Board With Grocery Code Next page： US FDA approves Pfizer's gene therapy for rare bleeding disorder

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Documents Reveal Canada Federal Govt's Efforts to Get Loblaw, Walmart On Board With Grocery Code

Apr 26, 2024

06:45 AM EDT, 04/26/2024 (MT Newswires) -- It was evident to the federal government as early as last fall that Loblaw ( LBLCF ) and Walmart might be holdouts to the grocery code of conduct, jeopardizing the project's success, The Canadian Press is reporting Friday, according to a story published on the BNN Bloomberg website. Documents obtained through access to...

US FDA approves Pfizer's gene therapy for rare bleeding disorder

Apr 26, 2024

April 26 (Reuters) - The U.S. Food and Drug Administration approved Pfizer's ( PFE ) gene therapy for hemophilia B on Friday, the second such therapy for the rare bleeding disorder that typically requires regular infusions of a blood-clotting protein. People with hemophilia have a fault in a gene that regulates production of proteins called clotting factors, which can cause...

Intel falls as weak PC chip demand hurts second-quarter forecast

Apr 26, 2024

(Reuters) - Intel ( INTC ) shares slumped more than 7% premarket on Friday after a downbeat second-quarter sales forecast signaled that the boom in AI technology was diverting enterprise spending away from its traditional data center and PC chips. The stock has fallen around 30% so far this year as Intel ( INTC ) trails rival chip companies like...

United Natural Foods Announces Pricing of $500 Million Term Loan Facility

Apr 26, 2024

06:51 AM EDT, 04/26/2024 (MT Newswires) -- United Natural Foods ( UNFI ) unveiled late Thursday the pricing of the refinancing of its senior secured term loan facility. The amended term loan facility will carry a duration of seven years, priced at the secured overnight financing rate plus 4.75% at an issue price of 98. Proceeds will be used to...